The International Congress on Drug Discovery and Development 2017 covers topics such as:
- Stereoselective Synthesis of Bioactive Compounds
- Systems Biology in Drug Design
- Recent Advances in Spectroscopy
- Regenerative Medicine
- Proteomics & Bioinformatics in Drug Discovery
- Pulmonary Drug Discovery & Therapy
- Pharmaceutical Research & Development
- Process Chemistry and Drug Manufacturing
- Innovative Drug Discovery and Nanotechnology
- In-silico Drug Design and In-Silico Screening
- Integrated Strategies for Drug Discovery
- Assay Development, Screening & Emerging Technologies
- Medicinal Chemistry & Imaging
- Computer Aided Drug Design
The International Congress on Drug Discovery and Development 2017 brings together:
- Clinicians involved in the prescription and/or review of therapeutic agents
- Academic and Industrial Scientists Associated with Discovery, Formulation and The Delivery of Drugs
- Researchers in clinical pharmacy, pharmacology and toxicology
- Regulatory and clinical scientists involved in drug development and drug registration
- Students and postdoctoral fellows in all areas of the Pharmaceutical Sciences
- Education providers in pharmacy, pharmacology and toxicology
- Medical practitioners such as clinical pharmacologists, clinical toxicologists, cardiologists and general physicians
- Government agencies involved in chemical safety assessment
- Drug Discovery Scientists, Medicinal Chemists, and Biotechnologists & Researchers from Pharmaceutical Industry R&D and Academic institutions
- Molecular and cellular pharmacologists
